Abstract
A chemoenzymatic strategy is described that can readily provide well-defined α(2,8)- and α(2,9)-linked oligosialic acids of different length. It employs the recombinant bacterial sialic acid polymerases, NmC-PST and NmB-PST, in combination with cytidine 5’-monophosphate N-acetylneuraminic acid (CMP-Neu5Ac) derivatives that have a benzoyl ester at C-9 or thioethyl ether at the C-5 acetamide of Neu5Ac. It results in products that lack glycosyl accepting properties and hence prevent polymerization. The benzoyl ester can be removed by mild basic hydrolysis and the thioethyl ether by reductive desulfurization to give natural Neu5Ac than can be extended in a next cycle of enzymatic sialylation and unmasking. The resulting oligosialosides are attractive materials for the development of bacterial vaccine and as probes to investigate the roles of oligosialosides in human physiology.
Supplementary materials
Title
Supporting information
Description
Supplementary schemes and figures, Experimental procedures, References, and NMR spectra
Actions



![Author ORCID: We display the ORCID iD icon alongside authors names on our website to acknowledge that the ORCiD has been authenticated when entered by the user. To view the users ORCiD record click the icon. [opens in a new tab]](https://www.cambridge.org/engage/assets/public/coe/logo/orcid.png)